Correspondence 0001493152-23-039045 from enVVeno Medical Corp (NVNO)

enVVeno Medical Corp
Date: Nov. 1, 2023 · CIK: 0001661053 · Accession: 0001493152-23-039045

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-275187

Date

October 26, 2023

Author

Chief

Form

CORRESP

Company

enVVeno Medical Corp

Letter

ENVVENO MEDICAL CORPORATION

Doppler

Irvine, California 92618

November 1, 2023

VIA EDGAR

U.S. Securities and Exchange Commission

Division of Corporation Finance

Office of Life Sciences

F Street, N.E.

Washington, DC 20549

Re:

enVVeno Medical Corporation

Registration Statement on Form S-3

Filed October 26, 2023

File No. 333-275187

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation, hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:00 p.m. EST on Friday, November 3, 2023, or as soon as thereafter practicable.

Very
truly yours,
/s/
Robert Berman

Show Raw Text

CORRESP
1
filename1.htm

ENVVENO
MEDICAL CORPORATION

70
Doppler

Irvine,
California 92618

November
1, 2023

VIA
EDGAR

U.S.
Securities and Exchange Commission

Division
of Corporation Finance

Office
of Life Sciences

100
F Street, N.E.

Washington,
DC 20549

    Re:

    enVVeno
    Medical Corporation

    Registration
    Statement on Form S-3

    Filed
    October 26, 2023

    File
    No. 333-275187

Ladies
and Gentlemen:

Pursuant
to Rule 461 under the Securities Act of 1933, as amended, enVVeno Medical Corporation, hereby requests acceleration of effectiveness
of the above referenced Registration Statement so that it will become effective at 4:00 p.m. EST on Friday, November 3, 2023, or as soon
as thereafter practicable.

    Very
    truly yours,

    /s/
    Robert Berman

    Robert
    Berman

    Chief
    Executive Officer

    cc:

    Ellenoff
    Grossman & Schole LLP

SecProbe.io